Global Health Equity
-
-
-
Johnson & Johnson Names Winners of First Africa Innovation Challenge
Competition Part of Company’s Eighty-Five Year Commitment to Supporting Entrepreneurs, Science Education Opportunities, and Health Systems Across the Continent -
Johnson & Johnson Announces World Health Organization will Review Ebola Vaccine Regimen for Emergency Use Assessment and Listing (EUAL)
Preparations also underway to initiate first-in-human study for multivalent vaccine regimen to combat Ebola, Sudan and Marburg viruses -
U.S. FDA Approves Vermox™ Chewable (Mebendazole) For Treatment of Children and Adults With Roundworm and Whipworm Infections
New tablet formulation provides alternative treatment for millions of children around the world infected by intestinal worms -
Johnson & Johnson Announces World Health Organization will Review Ebola Vaccine Regimen for Emergency Use Assessment and Listing (EUAL)
Preparations also underway to initiate first-in-human study for multivalent vaccine regimen to combat Ebola, Sudan and Marburg viruses -
U.S. FDA Grants Priority Review to Janssen’s New Drug Application for Chewable Mebendazole Tablets Intended to Treat Soil-Transmitted Helminthiasis
Johnson & Johnson shows ongoing commitment to London Declaration on NTDs through advancement of new chewable tablet -
-
New Idylla™ Ebola Virus Triage Test Granted Emergency Use Authorization by U.S. FDA
Co-Developed by Janssen Diagnostics, test will help prevent future outbreaks of Ebola
